Perioperative ascorbic acid supplementation does not reduce the incidence of postoperative atrial fibrillation in on-pump coronary artery bypass graft patients

Journal of Cardiology

Volumn 69, Issue 1, 2017, Pages 98-102

  Antonic, Miha ^a   Lipovec, Robert ^a   Gregorcic, Franc ^a   Juric, Peter ^a   Kosir, Gorazd ^a  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

Author keywords

Ascorbic acid; Atrial fibrillation; Coronary artery bypass grafting; Vitamin C

Indexed keywords

ASCORBIC ACID; ANTIOXIDANT;

ADULT; ARTICLE; ATRIAL FIBRILLATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ELECTIVE SURGERY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ON PUMP CORONARY ARTERY BYPASS GRAFT; PATIENT MONITORING; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VITAMIN SUPPLEMENTATION; AGED; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

AGED; ANTIOXIDANTS; ASCORBIC ACID; ATRIAL FIBRILLATION; CORONARY ARTERY BYPASS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 84964331156     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2016.01.010     Document Type: Article

References (34)

1. [1] Ommen, S.R., Odell, J.A., Stanton, M.S., Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 336 (1997), 1429–1434.
2. [2] Chung, M.K., Cardiac surgery: postoperative arrhythmias. Crit Care Med 28:Suppl. 10 (2000), N136–N144.
3. [3] Maisel, W.H., Rawn, J.D., Stevenson, W.G., Atrial fibrillation after cardiac surgery. Ann Intern Med 135 (2001), 1061–1073.
4. [4] Zaman, A.G., Archbold, A., Helft, G., Paul, E.A., Curzen, N.P., Mills, P.G., Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation 101 (2000), 1403–1408.
5. [5] Gasparovic, H., Bucar, I., Kopjar, T., Vojkovic, J., Gabelica, R., Biocina, B., Jelic, I., NT-pro-BNP, but not C-reactive protein, is predictive of atrial fibrillation in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg 37 (2010), 100–105.
6. [6] Budeus, M., Feindt, P., Gams, E., Wieneke, H., Sack, S., Erbel, R., Perings, C., Beta-blocker prophylaxis for atrial fibrillation after coronary artery bypass surgery in patients with sympathovagal imbalance. Ann Thorac Surg 84 (2007), 61–66.
7. [7] Kalavrouziotis, D., Buth, K.J., Ali, I.S., The impact of new-onset atrial fibrillation on in-hospital mortality following cardiac surgery. Chest 131 (2007), 833–839.
8. [8] Magee, M.J., Herbert, M.A., Dewey, T.M., Edgerton, J.R., Ryan, W.H., Prince, S., Mack, M.J., Atrial fibrillation after coronary artery bypass grafting surgery: development of a predictive risk algorithm. Ann Thorac Surg 83 (2007), 1707–1712.
9. [9] Omae, T., Kanmura, Y., Management of postoperative atrial fibrillation. J Anesth 26 (2012), 429–437.
10. [10] Hammwöhner, M., Smid, J., Lendecker, U., Goette, A., New drugs for atrial fibrillation. J Interv Card Electrophysiol 23 (2008), 15–21.
11. [11] Engelmann, M.D., Svendsen, J.H., Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 26 (2005), 2083–2092.
12. [12] Boos, C.J., Anderson, R.A., Is atrial fibrillation an inflammatory disorder. Eur Heart J 27 (2006), 136–149.
13. [13] Korantzopoulos, P., Kolettis, T., Siogas, K., Goudevenos, J., Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit 9 (2003), RA225–RA229.
14. [14] Neuman, R.B., Bloom, H.L., Shukrullah, I., Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem 53 (2007), 1652–1657.
15. [15] Korantzopoulos, P., Kolettis, T.M., Galaris, D., Goudevenos, J.A., The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 115 (2007), 135–143.
16. [16] Rodrigo, R., Prevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant system. Front Physiol, 3, 2012, 93.
17. [17] Carnes, C.A., Chung, M.K., Nakayama, T., Nakayama, H., Baliga, R.S., Piao, S., Kanderian, A., Pavia, S., Hamlin, R.L., McCarthy, P.M., Bauer, J.A., Van Wagoner, D.R., Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 89 (2001), E32–E38.
18. [18] Korantzopoulos, P., Kolettis, T.M., Kountouris, E., Dimitroula, V., Karanikis, P., Pappa, E., Siogas, K., Goudevenos, J.A., Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol 102 (2005), 321–326.
19. [19] Eslami, M., Sattarzadeh Badkoubeh, R., Mousavi, M., Radmehr, H., Salehi, M., Tavakoli, N., Avadi, M.R., Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting. Tex Heart Inst J 34 (2007), 268–274.
20. [20] Papoulidis, P., Ananiadou, O., Chalvatzoulis, E., Ampatzidou, F., Koutsogiannidis, C., Karaiskos, T., Madesis, A., Drossos, G., The role of ascorbic acid in the prevention of atrial fibrillation after elective on-pump mycoardial revascularization surgery: a single-center experience – a pilot study. Interact Cardiovasc Thorac Surg 12 (2011), 121–124.
21. [21] Bjordahl, P.M., Helmer, S.D., Gosnell, D.J., Wemmer, G.E., O'Hara, W., Milfeld, D.J., Perioperative supplementation with ascorbic acid does not prevent atrial fibrillation in coronary artery bypass graft patients. Am J Surg 204 (2012), 862–867.
22. [22] Ali-Hassan-Sayegh, S., Mirhosseini, S.J., Rezaeisadrabadi, M., Dehghan, H.R., Sedaghat-Hamedani, F., Kayvanpour, E., Popov, A.F., Liakopoulos, O.J., Antioxidant supplementation for prevention of atrial fibrillation after cardiac surgery: an updated comprehensive systematic review and meta-analysis of 23 randomized controlled trials. Interact Cardiovasc Thorac Surg 18 (2014), 646–654.
23. [23] Maisel, W.H., Rawn, J.D., Stevenson, W.G., Atrial fibrillation after cardiac surgery. Ann Intern Med 135 (2001), 1061–1073.
24. [24] Maesen, B., Nijs, J., Maessen, J., Allessie, M., Schotten, U., Post-operative atrial fibrillation: a maze of mechanisms. Europace 14 (2012), 159–174.
25. [25] Ferro, C.R., Oliveira, D.C., Nunes, F.P., Piegas, L.S., Postoperative atrial fibrillation after cardiac surgery. Arq Bras Cardiol 93 (2009), 59–63.
26. 2+ currents and human atrial fibrillation. Circ Res 85 (1999), 428–436.
27. + current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 80 (1997), 772–781.
28. [28] De Vecchi, E., Pala, M.G., Di Credico, G., Agape, V., Paolini, G., Bonini, P.A., Grossi, A., Paroni, R., Relation between left ventricular function and oxidative stress in patients undergoing bypass surgery. Heart 79 (1998), 242–247.
29. [29] Wilson, J.M., A day without orange juice is like an invitation to atrial fibrillation. Tex Heart Inst J 34 (2007), 265–267.
30. [30] Levine, M., Conry-Cantilena, C., Wang, Y., Welch, R.W., Washko, P.W., Dhariwal, K.R., Park, J.B., Lazarev, A., Graumlich, J.F., King, J., Cantilena, L.R., Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A 93 (1996), 3704–3709.
31. [31] Blanchard, J., Tozer, T.N., Rowland, M., Pharmacokinetic perspectives on megadoses of ascorbic acid. Am J Clin Nutr 66 (1997), 1165–1171.
32. [32] Hornig, D., Vuilleumier, J.P., Hartmann, D., Absorption of large, single, oral intakes of ascorbic acid. Int J Vitam Nutr Res 50 (1980), 309–314.
33. [33] Melethil, S., Mason, W.D., Chian-Jo, C., Dose-dependent absorption and excretion of vitamin C in humans. Int J Pharm 31 (1986), 83–89.
34. [34] Johnston, C.S., Thompson, L.L., Vitamin C status of an outpatient population. J Am Coll Nutr 17 (1998), 366–370.